InvestorsHub Logo
Followers 118
Posts 11972
Boards Moderated 0
Alias Born 12/18/2003

Re: None

Tuesday, 09/05/2023 5:50:02 PM

Tuesday, September 05, 2023 5:50:02 PM

Post# of 233151
" In this Country you need FDA approval "

Unfortunately this is true , and the drugs FDA like to approve are like Biogen Aduhelm for Alz,

--Big Pharma drugs
--Biogen here ,
--drug showing no clinical significance ,
--No p-value ,
--no endpoints met,
And about 30% of patients developing severe side effects ,including stroke..

This was a drug approved by FDA about one year ago...

No , FDA not interested to approve a drug from a small biotech , drug with not one severe side effect , and a great efficacy , when clinical studies are not sabotaged ...

---Drug finishing combo study in MDR HIV with 81% efficacy , when other 2 approved drugs at the time in 2018 , with severe side effects , are with 45 and 43% efficacy..
Efficacy is establish by patient VL ( viral load ) , tests done in a different labs , so we know , no mistakes here..

This is why Dr Arman said few times ,
No matter what happened , ALL our efficacy numbers are proper and didn't change..
in All the studies , in all the diseases ...

---And drug rug showing in a critical Covid patients , patients on the ventilators and ECMO , 82% mortality benefit ABOVE ANY OTHER DRUG use in covid ..
This is mortality , so one cant make a mistake here also , or patient died , or didn't .
And it showed 82% mortality benefit ABOVE ANY other drug , when leronlimab was in the system...

No , this is not a drug FDA like to approve,

I agree .

All imo.

GLTA longs.
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News